Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6743)
All Articles published online
|
Publishing Process of This Article
|
Jul 8, 2015 (publication date) through Jun 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lacaze L, Scotté M. Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma. World J Hepatol 2015; 7(13): 1755-1760 [PMID: 26167248 DOI: 10.4254/wjh.v7.i13.1755] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i13/1755.htm |
| Number | Citing Articles |
| 1 |
Qinqin Liu, Jing Li, Fei Liu, Weilin Yang, Jingjing Ding, Weixia Chen, Yonggang Wei, Bo Li, Lu Zheng. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy. Cancer Imaging 2020; 20(1) doi: 10.1186/s40644-020-00360-9
|
| 2 |
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]. 2019; doi: 10.5772/intechopen.86638
|
| 3 |
Yuemin Feng, Hao Wu, Daniel Q. Huang, Chenghui Xu, Hang Zheng, Mayumi Maeda, Xinya Zhao, Le Wang, Feng Xiao, Huanran Lv, Tiantian Liu, Jianni Qi, Jie Li, Ning Zhong, Chuanxi Wang, Hong Feng, Bo Liang, Wanhua Ren, Chengyong Qin, Mindie H. Nguyen, Qiang Zhu. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection. European Radiology 2020; 30(11): 6357 doi: 10.1007/s00330-020-06990-8
|
| 4 |
Jing Liang, Yi Bai, Fu-Shuang Ha, Ying Luo, Hui-Ting Deng, Ying-Tang Gao. Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2023; 15(1): 1-18 doi: 10.4251/wjgo.v15.i1.1
|
| 5 |
Qifan He, Jian Yang, Yonghai Jin. Development and Validation of TACE Refractoriness-Related Diagnostic and Prognostic Scores and Characterization of Tumor Microenvironment Infiltration in Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.869993
|
| 6 |
Junyu Wu, Cheng Zhang, Yau-Tuen Chan, Yuanjun Lu, Hor-Yue Tan, Yibin Feng, Ning Wang. Preoperative Immune Cells Infiltration in the Tumor Microenvironment as a Prediction and Prognostic Factor for Postoperative Recurrence in Hepatocellular Carcinoma. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4153442
|
| 7 |
Tomoki Kimura, Toshiki Fujiwara, Tsubasa Kameoka, Yoshinori Adachi, Shinji Kariya. The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC). Cancers 2022; 14(18): 4383 doi: 10.3390/cancers14184383
|
| 8 |
Junyu Wu, Yau‐Tuen Chan, Yuanjun Lu, Ning Wang, Yibin Feng. The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma. Medicinal Research Reviews 2023; 43(6): 1946 doi: 10.1002/med.21967
|
| 9 |
Nuozhou Wang, Ming-yue Li, Yi Liu, Jianqing Yu, Jianwei Ren, Zhiyuan Zheng, Shanshan Wang, Shucai Yang, Sheng-li Yang, Li-ping Liu, Bao-guang Hu, Charing CN. Chong, Juanita L. Merchant, Paul BS. Lai, George Gong Chen. ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway. Cancer Letters 2020; 472: 70 doi: 10.1016/j.canlet.2019.12.026
|
| 10 |
David Sooik Kim, Tae Seop Lim, Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Oidov Baatarkhuu, Seung Up Kim. Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis. Digestive Diseases and Sciences 2019; 64(12): 3660 doi: 10.1007/s10620-019-05701-8
|
| 11 |
Liyun Zheng, Shiji Fang, Fazong Wu, Weiqian Chen, Minjiang Chen, Qiaoyou Weng, Xulu Wu, Jingjing Song, Zhongwei Zhao, Jiansong Ji. Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study. Frontiers in Molecular Biosciences 2021; 7 doi: 10.3389/fmolb.2020.609322
|
| 12 |
Christof T. Kaltenmeier, Hamza Yazdani, Dirk van der Windt, Michele Molinari, David Geller, Allan Tsung, Samer Tohme. Neutrophil extracellular traps as a novel biomarker to predict recurrence-free and overall survival in patients with primary hepatic malignancies. HPB 2021; 23(2): 309 doi: 10.1016/j.hpb.2020.06.012
|
| 13 |
Ying He, Bin Hu, Chengzhan Zhu, Wenjian Xu, Yaqiong Ge, Xiwei Hao, Bingzi Dong, Xin Chen, Qian Dong, Xianjun Zhou. A Novel Multimodal Radiomics Model for Predicting Prognosis of Resected Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.745258
|
| 14 |
Timo Alexander Auer, Melina Anhamm, Georg Böning, Uli Fehrenbach, Wenzel Schöning, Georg Lurje, Bernhard Gebauer, Federico Collettini. Effectiveness and safety of computed tomography-guided high-dose-rate brachytherapy in treating recurrent hepatocellular carcinoma not amenable to repeated resection or radiofrequency ablation. European Journal of Surgical Oncology 2024; 50(7): 108429 doi: 10.1016/j.ejso.2024.108429
|
| 15 |
Gaëtan-Romain Joliat, Pierre Allemann, Ismail Labgaa, Nicolas Demartines, Nermin Halkic. Treatment and outcomes of recurrent hepatocellular carcinomas. Langenbeck's Archives of Surgery 2017; 402(5): 737 doi: 10.1007/s00423-017-1582-9
|
| 16 |
Junjie Liu, Jinming Zhao, H. A. O. Gu, Zhiqiang Zhu. Repeat hepatic resection VS radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma: an updated meta-analysis. Minimally Invasive Therapy & Allied Technologies 2022; 31(3): 332 doi: 10.1080/13645706.2020.1839775
|
| 17 |
Zeyu Wang, Ningning Zhang, Jiayu Lv, Cuihua Ma, Jie Gu, Yawei Du, Yibo Qiu, Zhiguang Zhang, Man Li, Yong Jiang, Jianqiu Zhao, Huiqin Du, Zhiwei Zhang, Wei Lu, Yan Zhang, Luca Miele. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/4037639
|
| 18 |
Zhenwei Peng, Shuling Chen, Mengchao Wei, Manxia Lin, Chunlin Jiang, Jie Mei, Bin Li, Yu Wang, Jiaping Li, Xiaoyan Xie, Minshan Chen, Guojun Qian, Ming Kuang. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation. Radiology 2018; 287(2): 705 doi: 10.1148/radiol.2018171541
|
| 19 |
_ _, Oszkár Hahn, Attila Szijártó, Damján Pekli, András Fülöp, Bálint Kokas, Dávid Bárdos, Csilla András, Péter Bartek, István Battyáni, János Bezsilla, György Bodoky, Attila Bursics, Magdolna Dank, Zsófia Dankovics, Ákos Deák Pál, Kristóf Dede, Gyula Demeter, Attila Doros, Ibolyka Dudás, Zsófia Egyed, Róbert Farkas, Zsuzsanna Gerlei, Tamás Györke, Krisztina Hagymási, Oszkár Hahn, Erika Hitre, József Hőhn, Viktor Jancsik, Zsolt Káposztás, István Király, András Kiss, László Kóbori, Péter Kupcsulik, Gábor Lakatos, István Lázár, Tamás Lóderer, Endre Nagy, Attila Oláh, Péter Pajor, András Papp, Gabriella Pár, Mihály Patyánik, Damján Pekli, Ágota Petrányi, András Petri, László Piros, János Schuller, László Sikorszki, József Szabó, Eszter Székely, Attila Szijártó, Andrea Szombati, László Torday, Judit Tóth, Lajos Barna Tóth, Edit Dósa, László Harsányi, Zsolt Horváth, Gábor István, László Landherr, György Lázár, Gabriella Lengyel, József Lővey, László Mangel, Pál Maurovich Horváth, Balázs Nemes, András Palkó, Zsuzsa Schaff, Ferenc Szalay, Ákos Szűcs, András Vereczkei. A hepatocellularis carcinoma komplex kezelése.. Orvosi Hetilap 2022; 162(Supplement-2): 2 doi: 10.1556/650.2021.32431
|
| 20 |
Hamzah Adwan, Lars Hammann, Thomas J. Vogl. Microwave Ablation of Recurrent Hepatocellular Carcinoma after Curative Surgical Resection. Journal of Clinical Medicine 2023; 12(7): 2560 doi: 10.3390/jcm12072560
|
| 21 |
Hongwei Zhao, Yubao Zhang, Jianmin Sun, Chao Zhan, Liang Zhao. Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2016; 23(5): 237 doi: 10.3727/096504016X14562725373671
|
| 22 |
Weidong Wang, Sinan Hou, JiaYan Ni, Hongliang Sun, Xiongying Jiang, Yaoting Chen, Linfeng Xu. Effectiveness and safety of irreversible electroporation for recurrent hepatocellular carcinoma ineligible for thermal ablation after surgery. Journal of Interventional Medicine 2020; 3(3): 151 doi: 10.1016/j.jimed.2020.07.009
|
| 23 |
Li Xie, Juan Yin, Ruyi Xia, Guihua Zhuang. Cost‐effectiveness of antiviral treatment after resection in hepatitis B virus–related hepatocellular carcinoma patients with compensated cirrhosis. Hepatology 2018; 68(4): 1476 doi: 10.1002/hep.29922
|
| 24 |
Jen-Lung Chen, Yaw-Sen Chen, Chen-Guo Ker. Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy. World Journal of Gastrointestinal Surgery 2023; 15(2): 258-272 doi: 10.4240/wjgs.v15.i2.258
|
| 25 |
Yoritaka Matsuno, Shintaro Yamazaki, Yusuke Mitsuka, Hayato Abe, Masamichi Moriguchi, Tokio Higaki, Tadatoshi Takayama. Subcuticular Sutures Versus Staples for Wound Closure in Open Liver Resection: A Randomised Clinical Trial. World Journal of Surgery 2021; 45(2): 571 doi: 10.1007/s00268-020-05833-3
|
| 26 |
Mohammed Yusuf Ansari, Alhusain Abdalla, Mohammed Yaqoob Ansari, Mohammed Ishaq Ansari, Byanne Malluhi, Snigdha Mohanty, Subhashree Mishra, Sudhansu Sekhar Singh, Julien Abinahed, Abdulla Al-Ansari, Shidin Balakrishnan, Sarada Prasad Dakua. Practical utility of liver segmentation methods in clinical surgeries and interventions. BMC Medical Imaging 2022; 22(1) doi: 10.1186/s12880-022-00825-2
|
| 27 |
Maria Tampaki, George Vasileios Papatheodoridis, Evangelos Cholongitas. Intrahepatic recurrence of hepatocellular carcinoma after resection: an update. Clinical Journal of Gastroenterology 2021; 14(3): 699 doi: 10.1007/s12328-021-01394-7
|
| 28 |
Shaoping Wang, Yujian Zheng, Jun Liu, Feng Huo, Jie Zhou. Analysis of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Recurrence following Liver Transplantation. Journal of Investigative Medicine 2018; 66(5): 1 doi: 10.1136/jim-2017-000655
|
| 29 |
Zhi‐Yuan Chen, Zhi‐Xing Guo, Liang‐He Lu, Jie Mei, Wen‐Ping Lin, Shao‐Hua Li, Wei Wei, Rong‐Ping Guo. The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early‐stage hepatocellular carcinoma. Cancer Medicine 2021; 10(16): 5466 doi: 10.1002/cam4.4102
|
| 30 |
Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Byung-Gon Na, Kyo-Won Lee, Gyu-Seong Choi, Joon Hyeok Lee. Nonanatomical resection is comparable with anatomical resection in solitary hepatocellular carcinoma <5 cm in the right posterior section. Medicine 2016; 95(51): e5382 doi: 10.1097/MD.0000000000005382
|
| 31 |
Byungje Bae, Keera Kang, Sung Kyu Song, Chul-Woon Chung, Yongkeun Park. Is partial hepatectomy a curable treatment option for hepatocellular carcinoma accompanied by cirrhosis? A meta-analysis and cure model analysis. Annals of Hepato-Biliary-Pancreatic Surgery 2022; 26(1): 47 doi: 10.14701/ahbps.21-080
|